Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (23)
COVID-19 (6)
Type
(
1 selected
)
Type
Guidance (1904)
NICE advice (320)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (225)
COVID-19 rapid guidelines (3)
Diagnostics guidance (50)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (603)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (341)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (797)
Apply filters
Showing 601 to 625 of 1904
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Atezolizumab monotherapy for untreated advanced non-small-cell lung cancer
TA705
2 June 2021
2 June 2021
Ibrutinib with obinutuzumab for untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (terminated appraisal)
TA702
26 May 2021
26 May 2021
Ibrutinib with rituximab for untreated chronic lymphocytic leukaemia (terminated appraisal)
TA703
26 May 2021
26 May 2021
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 2 or more anti-HER2 therapies
TA704
26 May 2021
26 May 2021
Electrohydraulic lithotripsy for difficult-to-treat bile duct stones
IPG698
26 May 2021
26 May 2021
Ex-situ machine perfusion for extracorporeal preservation of lungs (ex-vivo lung perfusion) for transplant
IPG695
26 May 2021
26 May 2021
Transvaginal laser therapy for stress urinary incontinence
IPG696
26 May 2021
26 May 2021
Transvaginal laser therapy for urogenital atrophy
IPG697
26 May 2021
26 May 2021
Heavy menstrual bleeding: assessment and management
NG88
14 March 2018
24 May 2021
Ravulizumab for treating paroxysmal nocturnal haemoglobinuria
TA698
19 May 2021
19 May 2021
Ofatumumab for treating relapsing multiple sclerosis
TA699
19 May 2021
19 May 2021
Crisaborole for treating mild to moderate atopic dermatitis in people 2 years and older (terminated appraisal)
TA701
19 May 2021
19 May 2021
HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography
MTG32
13 February 2017
19 May 2021
Parafricta Bootees and Undergarments to reduce skin breakdown in people with or at risk of pressure ulcers
MTG20
12 November 2014
19 May 2021
Andexanet alfa for reversing anticoagulation from apixaban or rivaroxaban
TA697
12 May 2021
12 May 2021
Permanent His-bundle pacemaker implantation for treating heart failure
IPG694
5 May 2021
5 May 2021
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia
MTG58
4 May 2021
4 May 2021
Pembrolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy
TA692
28 April 2021
28 April 2021
Bempedoic acid with ezetimibe for treating primary hypercholesterolaemia or mixed dyslipidaemia
TA694
28 April 2021
28 April 2021
Carfilzomib with dexamethasone and lenalidomide for previously treated multiple myeloma
TA695
28 April 2021
28 April 2021
Repetitive short-pulse transscleral cyclophotocoagulation for glaucoma
IPG692
28 April 2021
28 April 2021
Deep brain stimulation for chronic, severe, treatment-resistant obsessive-compulsive disorder in adults
IPG693
28 April 2021
28 April 2021
Avelumab for treating metastatic Merkel cell carcinoma
TA517
11 April 2018
21 April 2021
Acalabrutinib for treating chronic lymphocytic leukaemia
TA689
21 April 2021
21 April 2021
Avelumab for untreated metastatic Merkel cell carcinoma
TA691
21 April 2021
21 April 2021
Previous page
1
…
23
24
Current page
25
26
27
…
77
Page
25
of
77
Next page
Results per page
10
25
50
All
Back to top